Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge.
作者信息
Baden Lindsey R, El Sahly Hana M, Essink Brandon, Follmann Dean, Neuzil Kathleen M, August Allison, Clouting Heather, Fortier Gabrielle, Deng Weiping, Han Shu, Zhao Xiaoping, Leav Brett, Talarico Carla, Girard Bethany, Paila Yamuna D, Tomassini Joanne E, Schödel Florian, Pajon Rolando, Zhou Honghong, Das Rituparna, Miller Jacqueline
机构信息
Brigham and Women's Hospital, Boston, MA
Baylor College of Medicine, Houston, TX
出版信息
N Engl J Med. 2021 Dec 23;385(26):2485-2487. doi: 10.1056/NEJMc2115597. Epub 2021 Nov 3.
Abstract
摘要
相似文献
1
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge.Delta变异株激增期间mRNA-1273的3期试验。
N Engl J Med. 2021 Dec 23;385(26):2485-2487. doi: 10.1056/NEJMc2115597. Epub 2021 Nov 3.
2
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge.Delta变异株激增期间mRNA-1273 3期试验中的新冠病毒-19
medRxiv. 2021 Sep 22:2021.09.17.21263624. doi: 10.1101/2021.09.17.21263624.
3
COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020-October 2021.2020 年 12 月-2021 年 10 月美国 SARS-CoV-2 德尔塔变异株流行期间的 COVID-19 疫苗接种启动和剂次完成情况。
Public Health Rep. 2023 Jan-Feb;138(1):183-189. doi: 10.1177/00333549221123584. Epub 2022 Sep 21.
4
Levels of messenger ribonucleic acid for cholesterol side-chain cleavage cytochrome P-450 and 3 beta-hydroxysteroid dehydrogenase in bovine preovulatory follicles decrease after the luteinizing hormone surge.促黄体生成素激增后，牛排卵前卵泡中胆固醇侧链裂解细胞色素P-450和3β-羟基类固醇脱氢酶的信使核糖核酸水平降低。
Endocrinology. 1993 Feb;132(2):888-94. doi: 10.1210/endo.132.2.8425501.
5
Real-world vaccine effectiveness of mRNA vaccines for SARS-CoV-2; a test-negative case-control study in a medium-sized clinic.mRNA 疫苗对 SARS-CoV-2 的真实世界疫苗有效性：中等规模诊所的病例对照研究。
Hum Vaccin Immunother. 2022 Dec 30;18(7):2147353. doi: 10.1080/21645515.2022.2147353. Epub 2022 Dec 2.
6
SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.严重急性呼吸综合征冠状病毒2型B.1.1.529（奥密克戎）变种导致儿童住院人数前所未有的激增，且与严重急性呼吸综合征冠状病毒2型B.1.617.2（德尔塔）变种相比，临床表现有所不同。
Front Pediatr. 2022 Jun 27;10:932170. doi: 10.3389/fped.2022.932170. eCollection 2022.
7
Levels of messenger ribonucleic acid for cytochrome P450 17 alpha-hydroxylase and P450 aromatase in preovulatory bovine follicles decrease after the luteinizing hormone surge.促黄体生成素高峰后，排卵前牛卵泡中细胞色素P450 17α-羟化酶和P450芳香化酶的信使核糖核酸水平降低。
Endocrinology. 1993 May;132(5):2239-45. doi: 10.1210/endo.132.5.8477668.
8
Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation.衡量孟加拉国在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）德尔塔变异株激增期间使用的新冠疫苗的有效性：一项检测阴性设计评估。
Vaccines (Basel). 2022 Dec 2;10(12):2069. doi: 10.3390/vaccines10122069.
9
Oxytocin/neurophysin-I messenger ribonucleic acid in bovine granulosa cells increases after the luteinizing hormone (LH) surge and is stimulated by LH in vitro.牛颗粒细胞中的催产素/神经垂体素-I信使核糖核酸在促黄体生成素（LH）高峰后增加，并在体外受到LH的刺激。
Endocrinology. 1992 Dec;131(6):2755-62. doi: 10.1210/endo.131.6.1446614.
10
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study.新冠病毒19型B.1.617.2（德尔塔变异株）与B.1.1.7（阿尔法变异株）激增期的胸部CT及实验室特征：一项单中心病例对照研究
Infez Med. 2022 Dec 1;30(4):555-562. doi: 10.53854/liim-3004-10. eCollection 2022.
引用本文的文献
1
Highly immunogenic DNA/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques.高免疫原性DNA/LION纳米载体疫苗能有效激活猕猴的淋巴结，诱导产生持久免疫力。
iScience. 2025 Mar 18;28(4):112232. doi: 10.1016/j.isci.2025.112232. eCollection 2025 Apr 18.
2
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.3M-052-AF 联合 Alum 佐剂在 HIV 三聚体疫苗中的应用诱导人体自身中和抗体。
J Exp Med. 2024 Oct 7;221(10). doi: 10.1084/jem.20240604. Epub 2024 Sep 5.
3
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.黏膜型腺病毒疫苗加强免疫可诱导 IgA 产生，并可持久预防非人灵长类动物感染 XBB.1.16。
Nat Immunol. 2024 Oct;25(10):1913-1927. doi: 10.1038/s41590-024-01951-5. Epub 2024 Sep 3.
4
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.mRNA-1273 疫苗在成年人中的长期安全性和有效性：COVE 试验开放标签和加强针阶段。
Nat Commun. 2024 Aug 29;15(1):7469. doi: 10.1038/s41467-024-50376-z.
5
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.AZD1222（ChAdOx1 nCoV-19）的长期安全性和免疫原性：一项3期研究的2年随访
Vaccines (Basel). 2024 Aug 3;12(8):883. doi: 10.3390/vaccines12080883.
6
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.针对 NVX-CoV2373 疫苗在德尔塔浪潮中预防 COVID-19 的持久性。
Clin Infect Dis. 2024 Jul 19;79(1):78-85. doi: 10.1093/cid/ciae081.
7
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5.由BA.5毒株的稳定RBD纳米颗粒诱导的超高滴度和广泛的抗SARS-CoV-2中和作用
Vaccines (Basel). 2023 Dec 28;12(1):37. doi: 10.3390/vaccines12010037.
8
Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021.信使核糖核酸-1273在2021年3月至12月期间对年轻成年人预防严重急性呼吸综合征冠状病毒2感染的疗效。
Open Forum Infect Dis. 2023 Nov 2;10(11):ofad511. doi: 10.1093/ofid/ofad511. eCollection 2023 Nov.
9
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models.临床前动物模型中 DNA 和 mRNA COVID-19 疫苗诱导的免疫反应的描绘。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2281733. doi: 10.1080/21645515.2023.2281733. Epub 2023 Nov 27.
10
The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial.托珠单抗和巴瑞替尼联合治疗对重症 COVID-19 病例管理的影响：一项随机开放标签临床试验。
Front Pharmacol. 2023 Oct 19;14:1265541. doi: 10.3389/fphar.2023.1265541. eCollection 2023.
本文引用的文献
1
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.mRNA-1273 新型冠状病毒疫苗在盲法阶段完成时的效力。
N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22.
2
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2（德尔塔）变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
3
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
Zotero 插件